Stephen Tulipano

(Mr. Stephen Tulipano CPA)

Currently holds a position at Stoke Therapeutics Inc

Positions

Position Company Period
Chief Financial Officer Stoke Therapeutics Inc March 1, 2019 -
Chief Financial Officer, Treasurer Aldeyra Therapeutics Inc June 23, 2014 - July 27, 2018
Stephen Tulipano's trades of Stoke Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-19 2024-03-19
S Sale
4,116 -16.6%
6.10
USD 25,102 		4,116 -16.6% 6.10 USD 25,102
2021-02-24 2021-02-23
PS Planned sale
5,000 -89.3%
58.60
USD 292,992 		5,000 -89.3% 58.60 USD 292,992
2021-02-24 2021-02-22
PS Planned sale
102 -14.5%
60.00
USD 6,120 		102 -14.5% 60.00 USD 6,120
2021-02-24 2021-02-22
PS Planned sale
9,696 -93.2%
59.29
USD 574,842 		9,696 -93.2% 59.29 USD 574,842
2021-02-24 2021-02-22
PS Planned sale
15,202 -59.4%
58.67
USD 891,942 		15,202 -59.4% 58.67 USD 891,942
2020-11-04 2020-11-04
PS Planned sale
5,216 -89.7%
41.97
USD 218,910 		5,216 -89.7% 41.97 USD 218,910
2020-11-04 2020-11-04
PS Planned sale
11,111 -65.6%
41.42
USD 460,214 		11,111 -65.6% 41.42 USD 460,214
2020-11-04 2020-11-04
PS Planned sale
16,941 -50.0%
40.03
USD 678,086 		16,941 -50.0% 40.03 USD 678,086
2020-11-04 2020-11-03
PS Planned sale
1,732 -74.2%
39.84
USD 68,998 		1,732 -74.2% 39.84 USD 68,998
2020-11-04 2020-11-02
PS Planned sale
400 -39.9%
38.44
USD 15,374 		400 -39.9% 38.44 USD 15,374
2020-11-04 2020-11-02
PS Planned sale
14,445 -93.5%
37.86
USD 546,909 		14,445 -93.5% 37.86 USD 546,909
2020-11-04 2020-11-02
PS Planned sale
20,155 -56.6%
36.79
USD 741,448 		20,155 -56.6% 36.79 USD 741,448
// ... existing code ... // ... rest of the file ...